Stay updated on JUNIPER: ND-L02-s0201 in IPF Clinical Trial
Sign up to get notified when there's something new on the JUNIPER: ND-L02-s0201 in IPF Clinical Trial page.

Latest updates to the JUNIPER: ND-L02-s0201 in IPF Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe Locations section was updated with new site listings across multiple US states and international regions (Germany, Japan, United Kingdom). Several previously listed sites were removed.SummaryDifference2%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedThe page shows a revision update from v3.2.0 to v3.3.2, a minor UI/system change that does not alter study details or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedRemoved a generic government operating status notice from the page; core trial data, including the NCT03538301 study details, eligibility, and locations, remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check73 days agoChange DetectedResults for JUNIPER (NCT03538301) have been posted, including primary and secondary efficacy and safety outcomes. The record now shows the Results First Posted date and links to the detailed outcome tables.SummaryDifference0.3%

- Check95 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

- Check102 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0, indicating a version upgrade with no other content changes highlighted.SummaryDifference0.1%

Stay in the know with updates to JUNIPER: ND-L02-s0201 in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JUNIPER: ND-L02-s0201 in IPF Clinical Trial page.